Molecular Positron Emission Tomography and PET/CT Imaging in Urological Malignancies

This publication has 49 references indexed in Scilit:

• EAU Guidelines on Prostate Cancer
  European Urology, 2005
• Monitoring response to treatment in patients utilizing PET
  Radiologic Clinics of North America, 2005
• Clinical Applications of PET in Oncology
  Radiology, 2004
• Positron emission tomography provides molecular imaging of biological processes
  Proceedings of the National Academy of Sciences, 2000
• Radiosynthesis of 3′-deoxy-3′-[18F]fluorothymidine: [18F]FLT for imaging of cellular proliferation in vivo
  Nuclear Medicine and Biology, 2000
• Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography Is Useless for the Detection of Local Recurrence after Radical Prostatectomy
  European Urology, 1999
• Monoclonal Antibody Imaging of Occult Prostate Cancer in Patients With Elevated Prostate-Specific Antigen
  Clinical Nuclear Medicine, 1996
• Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.
  Radiology, 1996
• Metabolic Imaging of Untreated Prostate Cancer by Positron Emission Tomography with sup 18 Fluorine-Labeled Deoxyglucose
  Journal of Urology, 1996
• Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
  International Journal of Radiation Oncology*Biology*Physics, 1992